Lisa Smith, NP
Family · Joliet, ILNPI 1295218238
Payments from drug & device makers
Across 368 payments — averaging $16.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$881
- Otsuka America Pharmaceutical, Inc.$591
- AstraZeneca$564
- Nestle Healthcare Nutrition Inc.$514
- Lilly USA, LLC$448
- Pfizer$374
- plus $3K from 27 others
What the payments were for
- Food & beverage$6,135100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 51 | $881 |
| Otsuka America Pharmaceutical, Inc. | 33 | $591 |
| AstraZeneca | 35 | $564 |
| Nestle Healthcare Nutrition Inc. | 41 | $514 |
| Lilly USA, LLC | 31 | $448 |
| Pfizer | 21 | $374 |
| Novo Nordisk | 13 | $278 |
| Gilead | 16 | $268 |
| Boehringer Ingelheim | 14 | $244 |
| Aimmune Therapeutics, Inc. | 18 | $239 |
| GSK | 11 | $185 |
| Johnson & Johnson | 9 | $185 |
| Amgen(2 entities) | 8 | $174 |
| Sanofi-aventis U.S. LLC | 10 | $153 |
| Biohaven Pharmaceutical Holding Company Ltd. | 7 | $152 |
| Bayer | 9 | $132 |
| Merck | 8 | $128 |
| Novartis | 5 | $80 |
| Sunovion Pharmaceuticals Inc. | 3 | $70 |
| Astellas Pharma US Inc | 3 | $59 |
| Inspire Medical Systems, Inc. | 2 | $56 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 4 | $55 |
| Exact Sciences | 2 | $48 |
| Tersera Therapeutics LLC | 1 | $38 |
| Genentech USA, Inc. | 2 | $36 |
| Phathom Pharmaceuticals, Inc. | 2 | $33 |
| Hologic Sales And Service, LLC | 2 | $32 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $30 |
| Ardelyx, Inc. | 1 | $20 |
| Invivyd Inc | 1 | $19 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $18 |
| Mylan Specialty L.p. | 1 | $18 |
| E.r. Squibb & Sons, L.L.C. | 1 | $13 |
How this compares
$6,135 in reported general payments places this provider in the 95th percentile of 4,941 family providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 13 | $19,673 |
| UbrelvyUbrogepant | 11 | $12,594 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 44 | $1,647 |
| Fluticasone Propionate | 43 | $581 |
| Atorvastatin Calcium | 53 | $483 |
| Montelukast Sodium | 41 | $461 |
| Gabapentin | 31 | $441 |
| Simvastatin | 44 | $383 |
| Levothyroxine Sodium | 52 | $352 |
| Metoprolol Tartrate | 36 | $350 |
| Omeprazole | 40 | $292 |
| Potassium Chloride | 18 | $289 |
| Lisinopril | 31 | $281 |
| Diclofenac Sodium | 17 | $247 |
| Pantoprazole Sodium | 15 | $212 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance | $244 | $19,67313 claims |
| AbbVieUbrelvy | $881 | $12,59411 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 4,941 family providers in Illinois.
Other family in Joliet
- Ruth CarricoChicago$582K
- Aleksandra BielawiecBarrington$373K
- Erin SieberNaperville$334K
- Jamie BroganChicago$282K
- Ashley NoethGlen Carbon$271K
- Marita KametasChicago$259K
- Shammona ClarkChicago$247K
- Amanda McKeeMount Vernon$242K
- Brooke KennardBloomington$208K
- Amy BrownellElk Grove Village$202K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.